- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 15 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.16: 2 residues within 4Å:- Chain A: Y.28, N.61
Ligand excluded by PLIPNAG.17: 2 residues within 4Å:- Chain A: N.282
- Chain C: K.558
Ligand excluded by PLIPNAG.18: 1 residues within 4Å:- Chain A: N.603
Ligand excluded by PLIPNAG.19: 2 residues within 4Å:- Chain A: N.616, Q.644
Ligand excluded by PLIPNAG.20: 2 residues within 4Å:- Chain A: H.655, N.657
Ligand excluded by PLIPNAG.21: 3 residues within 4Å:- Chain A: N.709, I.1130, G.1131
Ligand excluded by PLIPNAG.22: 4 residues within 4Å:- Chain A: A.706, E.1072, K.1073, N.1074
Ligand excluded by PLIPNAG.23: 1 residues within 4Å:- Chain A: N.165
Ligand excluded by PLIPNAG.24: 2 residues within 4Å:- Chain B: Y.28, N.61
Ligand excluded by PLIPNAG.25: 2 residues within 4Å:- Chain A: K.558
- Chain B: N.282
Ligand excluded by PLIPNAG.26: 1 residues within 4Å:- Chain B: N.603
Ligand excluded by PLIPNAG.27: 2 residues within 4Å:- Chain B: N.616, Q.644
Ligand excluded by PLIPNAG.28: 2 residues within 4Å:- Chain B: H.655, N.657
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain B: N.709, I.1130, G.1131
Ligand excluded by PLIPNAG.30: 4 residues within 4Å:- Chain B: A.706, E.1072, K.1073, N.1074
Ligand excluded by PLIPNAG.31: 1 residues within 4Å:- Chain B: N.165
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain C: Y.28, N.61
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain B: K.558
- Chain C: N.282
Ligand excluded by PLIPNAG.34: 1 residues within 4Å:- Chain C: N.603
Ligand excluded by PLIPNAG.35: 2 residues within 4Å:- Chain C: N.616, Q.644
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain C: H.655, N.657
Ligand excluded by PLIPNAG.37: 3 residues within 4Å:- Chain C: N.709, I.1130, G.1131
Ligand excluded by PLIPNAG.38: 4 residues within 4Å:- Chain C: A.706, E.1072, K.1073, N.1074
Ligand excluded by PLIPNAG.39: 1 residues within 4Å:- Chain C: N.165
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Dejnirattisai, W. et al., The antigenic anatomy of SARS-CoV-2 receptor binding domain. Cell (2021)
- Release Date
- 2021-03-03
- Peptides
- Spike glycoprotein: ABC
COVOX-159 heavy Fab chain: DFH
COVOX-159 Fab light chain: EGI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DF
FH
HE
EG
GI
L
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 15 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Dejnirattisai, W. et al., The antigenic anatomy of SARS-CoV-2 receptor binding domain. Cell (2021)
- Release Date
- 2021-03-03
- Peptides
- Spike glycoprotein: ABC
COVOX-159 heavy Fab chain: DFH
COVOX-159 Fab light chain: EGI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DF
FH
HE
EG
GI
L